Head-to-head · WeighScore
Alan Meds vs Lighter You
The verdict
Lighter You takes it — 74.3/100 to 71.1/100.
Lighter You grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lighter You advertises tirzepatide at $169 a month and charges $339 per four weeks for it in its own store, a gap of roughly two to one on the same brand.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Alan Meds | Lighter You |
|---|---|---|
| WeighScore | 71.1/100 | 74.3/100 |
| Grade | C | C |
| Scorecard rank | #104 | #67 |
| Semaglutide | $158/mo (compounded) | $169 per 4 weeks (store and intake price; thirteen charges a year) |
| Tirzepatide | $295/mo (compounded) | $339 per 4 weeks (store and intake price; the marketing site advertises $169) |
| Coverage | 46 states | All 50 states plus Washington, D.C. (claimed; the footer says otherwise) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #104 · C
Strengths
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
- Multiple administration formats
Where it loses points
- Limited public information on program details
Graded #67 · C
Strengths
- The store and the intake agree with each other, so a reader who starts at the store sees the figure that will be charged
- Names four dispensing pharmacies with addresses and phone numbers
- Runs oral, microdose and injectable GLP-1 lines plus a separate peptide sub-brand, so the menu is unusually wide for the price band
- Unlimited video visits and dietitian check-ins are described as included in every plan
- A full refund is offered if a clinician declines the prescription
Where it loses points
- Tirzepatide is advertised at $169 a month on the marketing site and sold at $339 per four weeks in the store and the intake
- The marketing site says “/mo” and the store bills per four weeks, which is thirteen charges a year rather than twelve
- GLP-1 tablets are advertised at $249 and sold at $279 per four weeks; microdosing is advertised at $96 and sold at $179
- The peptide sub-brand prices the same products differently again — NAD+ at $199 against $229, sermorelin at $175 against $229
- The Terms claim all 50 states plus Washington, D.C. and the footer on the same site says not available in all 50 states
- No clinician, medical group or NPI is named, and no compounding class appears anywhere on the domain
- A dietitian visit is promised on the homepage with an asterisk that resolves to no footnote, and neither the Terms nor the refund policy promises one
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.